Switch to:
Biomarin Pharmaceutical Inc (NAS:BMRN)
EV/Revenue
20.73 (As of Today)

EV/Revenue ratio is calculated as enterprise value divided by its revenue. As of today, Biomarin Pharmaceutical Inc's enterprise value is $13,830.2 Mil. Biomarin Pharmaceutical Inc's revenue for the trailing twelve months (TTM) ended in Sep. 2014 was $667.1 Mil. Therefore, Biomarin Pharmaceutical Inc's EV/Revenue ratio for today is 20.73.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today, Biomarin Pharmaceutical Inc's stock price is $93.84. Biomarin Pharmaceutical Inc's revenue per share for the trailing twelve months (TTM) ended in Sep. 2014 was $4.50. Therefore, Biomarin Pharmaceutical Inc's P/S Ratio for today is 20.85.


Definition

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Biomarin Pharmaceutical Inc's EV/Revenue for today is calculated as:

EV/Revenue=Enterprise Value (Today)/Revenue (TTM)
=13830.211/667.059
=20.73

Biomarin Pharmaceutical Inc's current Enterprise Value is $13,830.2 Mil.
Biomarin Pharmaceutical Inc's Revenue for the trailing twelve months (TTM) ended in Sep. 2014 was 146.873 (Dec. 2013 ) + 151.552 (Mar. 2014 ) + 191.787 (Jun. 2014 ) + 176.847 (Sep. 2014 ) = $667.1 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Biomarin Pharmaceutical Inc's P/S Ratio for today is calculated as:

P/S Ratio=Share Price (Today)/Revenue Per Share (TTM)
=93.84/4.5
=20.85

Biomarin Pharmaceutical Inc's share price for today is $93.84.
Biomarin Pharmaceutical Inc's Revenue Per Share for the trailing twelve months (TTM) ended in Sep. 2014 was 1.03 (Dec. 2013 ) + 1.05 (Mar. 2014 ) + 1.31 (Jun. 2014 ) + 1.11 (Sep. 2014 ) = $4.50.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Revenue, P/S Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Biomarin Pharmaceutical Inc Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
ev2rev 34.0237.9117.0927.466.026.458.199.2912.1618.17

Biomarin Pharmaceutical Inc Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
ev2rev 10.4410.2912.1615.7614.3218.6718.1716.9814.2915.93
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK